News & Events
Bringing together the MS Society of India
MSIF staff paid a special visit to India this month to launch an exciting new collaboration with…
Research and relaxation: Russia’s World MS Day
The Russian MS Society embraced nature this World MS Day with a riverside seminar on MS treatment…
MS Ireland launches exciting new research report
MS Ireland took World MS Day as an opportunity to launch a pioneering research report, designed to…
Uruguayan media shines a light on World MS Day
TV stations, radio stations and newspapers across Uruguay shone a light on the many World MS Day…
Call for agencies and consultants: medicines regulation in Latin America
The winding path of MS progression
How the biological processes cause progression in different types of MS.
Brain damage in MS predicts long-term employment outcomes
A new study has found a link found between brain imaging markers and long-term employment status.
How EBV might cause immune cells to go rogue in MS
Study shows complex interaction between EBV and MS risk genes.
Brain volume changes may be key indicator for MS progression
New research suggests the rate of brain atrophy, or brain shrinkage, may be an important indicator of…
First therapy to treat pediatric MS approved in US
Fingolimod has been approved by the US Food and Drug Administration (FDA) as a treatment for children…
Creative brief: Arab region awareness raising campaign
MSIF is looking for an Arabic speaking experienced creative agency/consultant to develop a visual concept for an…
Japan MS Society hosts seventh annual seminar
The Japan MS Society invited people affected by MS, MS professionals and the public to its seventh…